
Vogliright 0.3mg Tablet
Marketer
Celera Pharma Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Vogliright 0.3mg Tablet
Diabelite 0.3mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. Prescribed when diet and other therapies prove insufficient, Diabelite 0.3mg should be ingested immediately before meals. Dosage and frequency are determined individually by your physician to optimize blood glucose control. Abrupt cessation is strongly discouraged; discontinuing without medical supervision risks dangerously elevated blood sugar, potentially leading to severe complications like renal impairment and vision loss. This medication is part of a comprehensive treatment plan, including a healthy diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include gas, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or troubling side effects to your doctor. While Diabelite 0.3mg itself doesn't induce hypoglycemia, combining it with other diabetes medications (especially insulin or sulfonylureas) increases this risk. Treat hypoglycemic episodes with plain glucose; ordinary table sugar is ineffective in this context. Inform your doctor of any pre-existing kidney or liver conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals must consult their physician prior to use. Always disclose all concurrent medications to ensure safe usage. Limit alcohol consumption as it may heighten the hypoglycemia risk.
Primary Ingredients of Vogliright 0.3mg Tablet
No text provided to rephrase.
Uses of Vogliright 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Vogliright 0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vogliright 0.3mg Tablet on an empty stomach.
Common Side effects of Vogliright 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vogliright 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Vogliright 0.3mg Tablet on an empty stomach.
How Vogliright 0.3mg Tablet works:
Diabetic patients may use Vogliright 0.3mg tablets to manage their blood sugar. This medication works by blocking the intestinal enzymes that digest complex carbohydrates, thus preventing post-meal spikes in blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vogliright 0.3mg Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Vogliright 0.3mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Vogliright 0.3mg tablets safely. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vogliright 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Vogliright 0.3mg tablets cautiously. Dosage modification for Vogliright 0.3mg tablets may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vogliright 0.3mg tablets. Dosage modification of Vogliright 0.3mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Vogliright 0.3mg Tablet :
Omit any missed dose of Vogliright 0.3mg Tablet and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Vogliright 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
